Legend Biotech · 9 hours ago
GxP Jr. Instructional Designer Intern
Legend Biotech is a global biotechnology company dedicated to treating life-threatening diseases. They are seeking a GxP Jr. Instructional Designer Intern to assist in creating and updating engaging eLearning modules for GxP training, applying adult learning principles and collaborating with SMEs.
BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Responsibilities
Update and maintain eLearning modules for consistency and effectiveness
Collaborate with SMEs and stakeholders to improve course design
Apply adult learning theories to develop learner-centered solutions
Create interactive and visually appealing content for digital training
Conduct quality assurance reviews to ensure accuracy and alignment with objectives
Qualification
Required
Graduate or Senior-level student in Instructional Design, Educational Technology, or related field
Proficiency with Articulate 360 platform
Strong communication, planning, and editing skills
Ability to manage multiple projects under tight deadlines
Preferred
Familiarity with AI tools (e.g., Copilot, Synthesia) is a plus
Benefits
Medical, dental, and vision insurance
401(k)-retirement plan with company match that vest fully on day one
Equity and stock options are available to employees in eligible roles
Eight weeks of paid parental leave after just three months of employment
Paid time off policy that includes vacation days, personal days, sick time, 11 company holidays, and 3 floating holidays
Flexible spending and health savings accounts
Life and AD&D insurance
Short- and long-term disability coverage
Legal assistance
Supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance
Commuter benefits
Family planning and care resources
Well-being initiatives
Peer-to-peer recognition programs
Company
Legend Biotech
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Funding
Current Stage
Public CompanyTotal Funding
$750.45M2023-05-05Post Ipo Equity· $350M
2022-07-25Post Ipo Equity· $250M
2020-06-05IPO
Recent News
2025-12-18
Company data provided by crunchbase